Dow Jones U.S. Pharmaceuticals Index
D.J. US Pharmaceutical Top 10: Value Investment Strategy
TOP 10 Value
VALUEVVV
GROWTHVV
SAFETYVV
COMBINED
1. Prestige (L, US) Pharmaceuticals
1. Prestige (L, US) Pharmaceuticals
79
60
30
80
2. Pfizer (XXL, US) Pharmaceuticals
2. Pfizer (XXL, US) Pharmaceuticals
75
30
22
27
3. Phibro Animal (L, US) Pharmaceuticals
3. Phibro Animal (L, US) Pharmaceuticals
67
22
32
29
4. Lannett (M, US) Pharmaceuticals
4. Lannett (M, US) Pharmaceuticals
51
60
36
70
5. Catalent (L, US) Pharmaceuticals
5. Catalent (L, US) Pharmaceuticals
41
83
45
100
June 8, 2018. Top 10s are published weekly by Top 10 schedule . (Free Stock Update )
D.J. US Pharmaceutical Top 10: Growth Investment Strategy
TOP 10 Growth
VALUEVVV
GROWTHVV
SAFETYVV
COMBINED
1. Supernus Pharma (M, US) Pharmaceuticals
1. Supernus Pharma (M, US) Pharmaceuticals
7
100
82
100
2. Nektar (L, US) Pharmaceuticals
2. Nektar (L, US) Pharmaceuticals
1
100
12
22
3. AbbVie (XXL, US) Biotechnology
3. AbbVie (XXL, US) Biotechnology
26
97
5
27
4. Catalent (L, US) Pharmaceuticals
4. Catalent (L, US) Pharmaceuticals
41
83
45
100
5. Eli Lilly (XXL, US) Pharmaceuticals
5. Eli Lilly (XXL, US) Pharmaceuticals
19
61
33
22
6. Zoetis (XL, US) Pharmaceuticals
6. Zoetis (XL, US) Pharmaceuticals
21
61
26
20
7. Prestige (L, US) Pharmaceuticals
7. Prestige (L, US) Pharmaceuticals
79
60
30
80
June 8, 2018. Top 10s are published weekly by Top 10 schedule . (Free Stock Update )
D.J. US Pharmaceutical Top 10: Safety Investment Strategy
TOP 10 Safety
VALUEVVV
GROWTHVV
SAFETYVV
COMBINED
1. Supernus Pharma (M, US) Pharmaceuticals
1. Supernus Pharma (M, US) Pharmaceuticals
7
100
82
100
2. Pacira BioSciences (M, US) Pharmaceuticals
2. Pacira BioSciences (M, US) Pharmaceuticals
5
33
50
33
3. Bristol-Myers Squibb (XXL, US) Pharmaceuticals
3. Bristol-Myers Squibb (XXL, US) Pharmaceuticals
10
40
49
16
4. Catalent (L, US) Pharmaceuticals
4. Catalent (L, US) Pharmaceuticals
41
83
45
100
5. Johnson & Johnson (XXL, US) Pharmaceuticals
5. Johnson & Johnson (XXL, US) Pharmaceuticals
17
40
38
16
June 8, 2018. Top 10s are published weekly by Top 10 schedule . (Free Stock Update )
D.J. US Pharmaceutical Top 10: Combined Investment Strategy
TOP 10 Combined
VALUEVVV
GROWTHVV
SAFETYVV
COMBINED
1. Supernus Pharma (M, US) Pharmaceuticals
1. Supernus Pharma (M, US) Pharmaceuticals
7
100
82
100
2. Catalent (L, US) Pharmaceuticals
2. Catalent (L, US) Pharmaceuticals
41
83
45
100
3. Prestige (L, US) Pharmaceuticals
3. Prestige (L, US) Pharmaceuticals
79
60
30
80
4. Lannett (M, US) Pharmaceuticals
4. Lannett (M, US) Pharmaceuticals
51
60
36
70
5. Pacira BioSciences (M, US) Pharmaceuticals
5. Pacira BioSciences (M, US) Pharmaceuticals
5
33
50
33
June 8, 2018. Top 10s are published weekly by Top 10 schedule . (Free Stock Update )
☀ This company has a special achievement which is documented on its stock research page.
Top 10 lists may contain fewer than 10 stocks due to Obermatt’s top 10 quality standards .
Top 10 Stocks from the purely finance fact-based Obermatt Method for the investment strategies Value , Growth and Safety in the stock index Dow Jones U.S. Pharmaceuticals Index from June 8, 2018.
Top 10 Stock History D.J. US Pharmaceutical
Select Top 10 Date
Apr‑2021
Jan‑2021
Aug‑2020
Mar‑2020
Oct‑2019
Apr‑2019
Nov‑2018
Jun‑2018
Oct‑2017
Apr‑2017
Jan‑2017
Jan‑2016
Jan‑2015
Jan‑2014